Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors

Regulatory Peptides

Volumn 149, Issue 1-3, 2008, Pages 56-59

  Ukkola, Olavi ^a   Kunnari, Anne ^a   Kesäniemi, Y Antero ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Glucose; Hypertension; Insulin resistance; Polymorphisms; Resistin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; RESISTIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FINLAND; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FINLAND; GENE FREQUENCY; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HOMOZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN TIME; RESISTIN; RISK FACTORS; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 48849110416     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.08.025     Document Type: Article

References (22)

1. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
2. Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., and Lazar M.A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53 (2004) 1937-1941
3. Satoh H., Nguyen M.T., Miles P.D., Imamura T., Usui I., and Olefsky J.M. Adenovirus-mediated chronic 'hyper-resistinemia' leads to in vivo insulin resistance in normal rats. J Clin Invest 114 (2004) 224-231
4. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., Zhu Q., and Considine R.V. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88 (2003) 5452-5455
5. Azuma K., Katsukawa F., Oguchi S., Murata M., Yamazaki H., Shimada A., and Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11 (2003) 997-1001
6. McTernan P.G., Fisher F.M., Valsamakis G., Chetty R., Harte A., McTernan C.L., Clark P.M., Smith S.A., Barnett A.H., and Kumar S. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 88 (2003) 6098-6106
7. Zhang J.L., Qin Y.W., Zheng X., Qiu J.L., and Zou D.J. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 20 (2003) 828-831
8. Lee J.H., Chan J.L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., and Mantzoros C.S. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88 (2003) 4848-4856
9. Utzschneider K.M., Carr D.B., Tong J., Wallace T.M., Hull R.L., Zraika S., Xiao Q., Mistry J.S., Retzlaff B.M., Knopp R.H., and Kahn S.E. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48 (2005) 2330-2333
10. Kunnari A., Ukkola O., Paivansalo M., and Kesaniemi Y.A. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 91 7 (2006) 2755-2760
11. Smith S.R., Bai F., Charbonneau C., Janderová L., and Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52 (2003) 1611-1618
12. Cho Y.M., Youn B.S., Chung S.S., Kim K.W., Lee H.K., Yu K.Y., Park H.J., Shin H.D., and Park K.S. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47 (2004) 559-565
13. Osawa H., Yamada K., Onuma H., Murakami A., Ochi M., Kawata H., Nishimiya T., Niiya T., Shimizu I., Nishida W., Hashiramoto M., Kanatsuka A., Fujii Y., Ohashi J., and Makino H. The G/G genotype of a resistin single-nucleotide polymorphism at - 420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75 (2004) 678-686
14. Conneely K.N., Silander K., Scott L.J., Mohlke K.L., Lazaridis K.N., Valle T.T., Tuomilehto J., Bergman R.N., Watanabe R.M., Buchanan T.A., Collins F.S., and Boehnke M. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47 (2004) 1782-1788
15. Engert J.C., Vohl M.C., Williams S.M., Lepage P., Loredo-Osti J.C., Faith J., Dore C., Renaud Y., Burtt N.P., Villeneuve A., Hirschhorn J.N., Altshuler D., Groop L.C., Despres J.P., Gaudet D., and Hudson T.J. 5' flanking variants of resistin are associated with obesity. Diabetes 51 5 (2002) 1629-1634
16. Kunnari A., Ukkola O., and Kesäniemi Y.A. Resistin polymorphisms are associated with cerebrovascular disease in Finnish type 2 diabetic patients. Diabet Med 22 5 (2005) 583-589
17. Sentinelli F., Romeo S., Arca M., Filippi E., Leonetti F., Banchieri M., Di Mario U., and Baroni M.G. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 51 (2002) 860-862
18. Osawa H., Onuma H., Murakami A., Ochi M., Nishimiya T., Kato K., Shimizu I., Fujii Y., Ohashi J., and Makino H. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 51 (2002) 863-866
19. Rantala A.O., Kauma H., Lilja M., Savolainen M.J., Reunanen A., and Kesäniemi Y.A. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 245 (1999) 163-174
20. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., and Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
21. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 15 (1998) 539-553
22. Xu J.Y., Sham P.C., Xu A., Tso A.W., Wat N.M., Cheng K.Y., Fong C.H., Janus E.D., and Lam K.S. Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study. Clin Endocrinol (Oxf) 66 2 (2007) 211-217